Iambic Therapeutics, Inc
1 clinical trials · Sponsor
◉ Watch Iambic Therapeutics, Inc
| Record | Firm | Date |
|---|---|---|
| A Phase 1/1b Study of IAM1363 in HER2 Cancers (NCT06253871) | Iambic Therapeutics, Inc | 2024-03-25 |
Track Iambic Therapeutics, Inc automatically
Every clearance here is in the API, with alerts when new ones post.